Package 16729-549-10

{"route": ["SUBLINGUAL"], "spl_id": "799f8804-485e-46ca-b6c6-243f790f80e2", "openfda": {"upc": ["0316729550109", "0316729549103"], "unii": ["5Q187997EE", "56W8MW3EN1"], "rxcui": ["351266", "351267"], "spl_set_id": ["35d29e9b-9950-452a-a795-5a7514f0edfd"], "manufacturer_name": ["Accord Healthcare, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (16729-549-10)", "package_ndc": "16729-549-10", "marketing_start_date": "20200901"}], "brand_name": "BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE", "product_id": "16729-549_799f8804-485e-46ca-b6c6-243f790f80e2", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "16729-549", "dea_schedule": "CIII", "generic_name": "BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE", "labeler_name": "Accord Healthcare, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": ".5 mg/1"}], "application_number": "ANDA209069", "marketing_category": "ANDA", "marketing_start_date": "20200901", "listing_expiration_date": "20261231"}